The National Protocol to ensure the health and safety of company employees in the face of the COVID-19 epidemic published on October 29, 2020, allows companies to offer their employees who are volunteers a screening for COVID-19 in the event of doubt about their virological status, as soon as suggestive symptoms appear. Annex 1 sets out the framework and general conditions for implementing antigen testing campaigns.
A circular of December 14, 2020 completes this framework with regard to access to testing within companies, in the light of available scientific analyzes. A “deployment kit”, which lists all the technical prerequisites, as well as a kit for use by healthcare professionals and another for patients, are attached.
The overall objective is to allow employees (primarily symptomatic whose symptoms appeared during their presence in the company, and asymptomatic when they are contact persons, identified individually or within a cluster) to easily and quickly access a test offered in their professional environment in order to remove any doubt: the process has a diagnostic purpose and must be implemented in a medical logic by authorized professionals.
–
ARTICLE RESERVED FOR SUBSCRIBERS
Access all of this news
on subscriptions
PREMIUM and UNLIMITED
–
Immediate access to content
–
–
–
–
–
